Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions. The Advanced Therapies segment offers advanced therapy products, services, and solutions to the therapy departments of healthcare providers. The Diagnostics segment provides diagnostic products and services, including a range of testing applications, in the areas of laboratory, point of care, and molecular diagnostics. Siemens Healthineers AG is based in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Industry, Sector and Symbol
Stock Exchange ETR
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
SymbolETR:SHL
CUSIPN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
Siemens Healthineers (ETR:SHL) Frequently Asked Questions
What is Siemens Healthineers' stock symbol?
Siemens Healthineers trades on the ETR under the ticker symbol "SHL."
What price target have analysts set for SHL?
17 Wall Street analysts have issued 1 year price targets for Siemens Healthineers' stock. Their predictions range from €33.00 to €43.00. On average, they expect Siemens Healthineers' share price to reach €37.24 in the next year. This suggests that the stock has a possible downside of 1.6%. View Analyst Price Targets for Siemens Healthineers.
What is the consensus analysts' recommendation for Siemens Healthineers?
17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Siemens Healthineers in the last year. There are currently 12 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Siemens Healthineers.
Who are some of Siemens Healthineers' key competitors?
Some companies that are related to Siemens Healthineers include Sartorius AG Preference Shares (SRT3), Carl Zeiss Meditec (AFX), Senseonics (SENS), MaxCyte (MXCT), Palatin Technologies (PTN), EPIGENOMICS AG/S (EPGNY), Oncimmune (ONC), Profound Medical (PRN), Lexagene (LXG), Sernova (SVA), Co-Diagnostics (CODX), SQI Diagnostics (SQD), Parallax Health Sciences (PRLX), Cambridge Cognition (COG) and LED Medical Diagnostics (LMD).
Has Siemens Healthineers been receiving favorable news coverage?
News headlines about SHL stock have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Siemens Healthineers earned a coverage optimism score of 0.14 on Accern's scale. They also assigned news headlines about the company an impact score of 46.99 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future. View Recent Headlines for Siemens Healthineers.
What is Siemens Healthineers' stock price today?
One share of SHL stock can currently be purchased for approximately €37.85.
MarketBeat Community Rating for Siemens Healthineers (ETR SHL)
MarketBeat's community ratings are surveys of what our community members think about Siemens Healthineers and other stocks. Vote "Outperform" if you believe SHL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SHL will underperform the S&P 500 over the long term. You may vote once every thirty days.
